BioIVT acquired donor center and laboratory in London

| By | Blood Products, Drug Development
0
117

BioIVT, a leading provider of research models and services for drug development, acquired Clinical Trials Laboratory Services (CTLS), a donor center and laboratory based in London (UK).

CTLS provides dedicated high-quality serum, plasma and blood collection services. It also offers full-service cell processing capabilities on site. London headquarters of CTLS will become the primary site in Europe for donor collections.

This acquisition increases BioIVT’s capacity to produce fresh peripheral blood mononuclear cells and other immune cell subsets such as natural killer cells, B cells, and T cells to meet clients’ research needs. It also enables BioIVT to ship fresh blood and blood-derived products to researchers anywhere in Europe within 24 hours.

BioIVT (Westbury, New York, USA) formerly BioreclamationIVT, is a leading global provider of research models and value-added research services for drug discovery and development. The company specializes in control and disease-state biospecimens including human and animal tissues, cell products, blood, and other biofluids.

SOURCE: bioivt
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.